2016
DOI: 10.1007/s13193-016-0525-1
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Lymphomatoid Granulomatosis- a Case Report with Review of Literature

Abstract: Lymphomatoid granulomatosis is a rare, Epstein Barr Virus (EBV)-associated systemic angiodestructive disorder that may progress to a diffuse large B cell lymphoma. Pulmonary involvement occurs in over 90 % cases followed by kidney, skin and brain. WHO classifies lymphomatoid granulomatosis under the generic heading of B cell proliferations of uncertain malignant potential. Radiologically, pulmonary lymphomatoid granulomatosis (PLG) presents with non specific findings making histopathology the gold standard for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…PPL, with a low incidence, comprises < 1% [ 1 ] of all non-Hodgkin’s lymphoma (NHL), and 0.5% of all primary pulmonary malignant tumors [ 2 , 3 ]. Traditionally, it has been defined as a clonal lymphoid proliferation affecting one or both lungs (parenchyma and/or bronchi) in a patient with no clinical, pathological, or radiographic evidence of lymphoma elsewhere, either in the past, or at present, or for 3 months after presentation [ 4 , 5 ]. The vast majority are type of low-grade mucosa-associated lymphoid tissue [ 6 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…PPL, with a low incidence, comprises < 1% [ 1 ] of all non-Hodgkin’s lymphoma (NHL), and 0.5% of all primary pulmonary malignant tumors [ 2 , 3 ]. Traditionally, it has been defined as a clonal lymphoid proliferation affecting one or both lungs (parenchyma and/or bronchi) in a patient with no clinical, pathological, or radiographic evidence of lymphoma elsewhere, either in the past, or at present, or for 3 months after presentation [ 4 , 5 ]. The vast majority are type of low-grade mucosa-associated lymphoid tissue [ 6 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…Обнаружение признаков гранулематозного процесса в легочной ткани у пациентов с БШ является показанием для исключения сопутствующего инфекционного процесса (в особенности при проведении иммуносупрессивной терапии), саркоидоза, гранулематоза с полиангиитом [32,43] или онкогематологических заболеваний (солидные опухоли или лимфомы) [93,94].…”
Section: синдром берта -хогга -дьюбаunclassified